{{Rsnum
|rsid=1043763
|Gene=MLXIP
|Chromosome=12
|position=122146362
|Orientation=plus
|GMAF=0.3274
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MLXIP
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 56.6 | 37.2 | 6.2
| HCB | 29.9 | 47.4 | 22.6
| JPT | 47.8 | 39.8 | 12.4
| YRI | 28.6 | 49.7 | 21.8
| ASW | 38.6 | 40.4 | 21.1
| CHB | 29.9 | 47.4 | 22.6
| CHD | 26.6 | 59.6 | 13.8
| GIH | 56.4 | 33.7 | 9.9
| LWK | 24.5 | 60.9 | 14.5
| MEX | 53.4 | 34.5 | 12.1
| MKK | 46.8 | 42.2 | 11.0
| TSI | 73.5 | 22.5 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=7E-6
  |OR=1.50
  |ORtxt=[1.248-1.795]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}